Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NTLA
SEPN
Add up to 3 more stocks
NTLA
Intellia Therapeutics, Inc.
-2.98%
$12.37-0.38Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.73B
52W Range
$7.95 - $28.25
SEPN
Septerna Inc
-5.81%
$35.67-2.20Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.61B
52W Range
$17.55 - $51.10
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.38 | 4.16 |
| P/S Ratio | 29.05 | 16.26 |
| P/FCF Ratio | N/A | 15.30 |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 76.5% | 99.6% |
| Operating Margin | -651.7% | -175.8% |
| Net Margin | -672.2% | -24.5% |
| ROE | -55.0% | -6.3% |
| ROA | -46.7% | -4.3% |
| ROIC | -54.5% | -8.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.65 | 4.99 |
| Quick Ratio | 6.65 | 4.99 |
| Debt/Equity | 0.10 | 0.06 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.